Two years of treatment with seladelpar, Gilead Sciences’ oral candidate, safely results in rapid and sustained reductions in itching…
Articles by Marisa Wexler, MS
The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Ipsen’s elafibranor as a second-line treatment for…
An imaging technique called holomedicine helped surgeons in Singapore make sure they removed a part of a liver from a…
A test-and-treat strategy was effective at identifying and treating hepatitis C among migrants and refugees in Italy coming from…
Treatment with Ocaliva (obeticholic acid) — an oral therapy with conditional approval in both the U.S. and Europe —…
Children with biliary atresia who have a serious condition called acute-on-chronic liver failure (ACLF) tend to require a longer stay…
An intermittent fasting regimen reduced liver fat buildup and lowered the likelihood of liver cancer in mouse models of metabolic…
Primary biliary cholangitis (PBC), a rare autoimmune liver disease, shares 10 genetic risk factors with inflammatory bowel disease (IBD),…
Reduced activity of a protein called GPR75 appears to help prevent the buildup of fat in the liver and the…
Researchers at the University of California San Diego (UCSD) have created a molecule, named antisense oligonucleotide (ASO) 56, that is…